Economic burden of bronchiectasis in Germany

Roland Diel, James D. Chalmers, Klaus F. Rabe, Albert Nienhaus, Robert Loddenkemper, Felix C. Ringshausen

Source: Eur Respir J, 53 (2) 1802033; 10.1183/13993003.02033-2018
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Roland Diel, James D. Chalmers, Klaus F. Rabe, Albert Nienhaus, Robert Loddenkemper, Felix C. Ringshausen. Economic burden of bronchiectasis in Germany. Eur Respir J, 53 (2) 1802033; 10.1183/13993003.02033-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Healthcare utilization and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014

Bronchiectasis among hospitalised patients in Germany
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Economic consequences of idiopathic pulmonary fibrosis in Denmark
Source: ERJ Open Res, 4 (2) 00045-2017; 10.1183/23120541.00045-2017
Year: 2018



Economic burdens of patients with chronic obstructive pulmonary disease (COPD) in Japan
Source: Eur Respir J 2006; 28: Suppl. 50, 108s
Year: 2006

The burden of chronic obstructive pulmonary disease (COPD) in Taiwan
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013


Current and future costs of COPD in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013

Asthma: prevalence and cost of illness
Source: Eur Respir J 2005; 25: 47-53
Year: 2005



Economic costs of severe asthma in omalizumab-treated patients. FENOMA Study
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017


The burden of multi-cause and pneumococcal pneumonia hospitalisations in the RhÔne-Alpes region, France (2005–2010)
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Healthcare resource utilization and direct costs of interstitial lung disease management in Germany
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019


Economic impact of pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 472s
Year: 2004

Cost-of-illness of COPD in Germany
Source: Eur Respir J 2003; 22: Suppl. 45, 376s
Year: 2003

Healthcare costs and resource use in patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Current and future costs of asthma in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013

Detection of tuberculous etiology of bronchiectasis in a high burden TB country
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


The disease burden of mild asthmatics in China
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


Late Breaking Abstract - Assessing epidemiology and costs of asthma and COPD in Switzerland with health insurance data
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018


Development of a national patient charter for idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF clinical
Year: 2016


Prevalence of chronic obstructive pulmonary disease (COPD) amongst farmers in rural India
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015


Estimates of chronic obstructive pulmonary disease in terms of prevalence, mortality and costs for England and Scotland for 2011 and 2030
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014